Study to Evaluate the Immunogenicity and Safety of a Second Vaccination With the Adjuvanted Influenza Vaccine Candidate

NCT00385840 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

678

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Influenza Vaccine GSK1247446A
BIOLOGICAL: FluarixTM

Sponsor

GlaxoSmithKline